Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.
about
Role of insulin in the type 2 diabetes therapy: past, present and future[Fast-acting insulin - new developments towards more flexibility for the patient].Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase.Reduction of postprandial glycemic excursions in patients with type 1 diabetes: a novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin.Clinical hurdles and possible solutions in the implementation of closed-loop control in type 1 diabetes mellitus.Diabetes mellitus: new challenges and innovative therapies.Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidaseComparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase.Enhanced absorption of insulin aspart as the result of a dispersed injection strategy tested in a randomized trial in type 1 diabetic patients.A review of artificial pancreas technologies with an emphasis on bi-hormonal therapySubcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase.Review of the mechanism of action and clinical efficacy of recombinant human hyaluronidase coadministration with current prandial insulin formulations.Closed-loop insulin delivery: from bench to clinical practice.Ultrafast-acting insulins: state of the artMoving toward the ideal insulin for insulin pumps.Development of glucose-responsive 'smart' insulin systems.Confusion Regarding Duration of Insulin Action: A Potential Source for Major Insulin Dose Errors by Bolus Calculators.
P2860
Q22241148-1E4517F8-9019-4134-B7B8-14709610430BQ30313628-CEE03A03-F9D4-4BC0-94ED-11EC0ABBC0D9Q34583346-BD88738B-CFC3-4EEC-AF01-BD005351E6C9Q35337607-FA6EDC00-787E-420A-929F-050CA05F0E1FQ35529700-B6CA9357-BA9C-4530-9414-93D25F467797Q36117595-9108014E-3616-4E40-B703-69AAE9686F91Q36229266-453C7A5F-38B7-4AF8-86E3-9FA610009CAFQ36229271-94C80E16-1CB3-4903-8125-D8D761F889FCQ36560273-9D09B519-3BC2-4601-8492-E6CCA7CA631FQ36720392-FDA78674-1BAA-4AD4-B719-CD34C9563CECQ37154369-A1F05507-E5E4-4802-AFD2-18253559BE1FQ37182157-845183D4-43EB-4012-BF51-86C704FC027FQ37716042-60EA1592-A1ED-4963-967C-349A7A562771Q37846089-DF56F0E7-AFBB-4282-97D1-B88873998B49Q38037727-73A86C6C-969C-4C0D-8E0C-876623E3BCCFQ38631154-16E87D87-18C8-4B58-B57E-4E1B30692C5AQ39309814-1D1811E8-14BA-4E60-90AE-C4BFFA7ACC73Q41873997-A1DE855A-078A-446B-BDD5-D160BDE31D63
P2860
Accelerated pharmacokinetics and glucodynamics of prandial insulins injected with recombinant human hyaluronidase.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Accelerated pharmacokinetics a ...... combinant human hyaluronidase.
@en
Accelerated pharmacokinetics a ...... combinant human hyaluronidase.
@nl
type
label
Accelerated pharmacokinetics a ...... combinant human hyaluronidase.
@en
Accelerated pharmacokinetics a ...... combinant human hyaluronidase.
@nl
prefLabel
Accelerated pharmacokinetics a ...... combinant human hyaluronidase.
@en
Accelerated pharmacokinetics a ...... combinant human hyaluronidase.
@nl
P2093
P356
P1476
Accelerated pharmacokinetics a ...... combinant human hyaluronidase.
@en
P2093
Andrew M Vick
Barry J Sugarman
Daniel E Vaughn
Douglas B Muchmore
Gregory I Frost
Igor P Bilinsky
Richard C Yocum
P304
P356
10.1089/DIA.2009.0013
P577
2009-06-01T00:00:00Z